top of page
About
Brands
Investors
Press
Governance
Contact
Press Releases
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
May 22, 2024
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
May 1, 2024
Annual report 2023 InterCure LTD.
May 1, 2024
bottom of page
